Literature DB >> 10982345

Effects of genomic length on translocation of hepatitis B virus polymerase-linked oligomer.

T C Ho1, K S Jeng, C P Hu, C Chang.   

Abstract

Accurate translocation of the polymerase-linked oligomer to the acceptor site (DR1*) in reverse transcription is crucial for maintaining the correct size of the hepatitis B virus (HBV) genome. Various sizes of foreign sequences were inserted at different sites of the HBV genome, and their effects on accurate translocation of polymerase-linked oligomer to DR1* were tested. Three types of replicate DNA products were observed in these insertion mutants: RC (relaxed circle) and type I and type II DL (duplex linear) DNA. Our results indicated that the minus strand of RC and type I DL form was elongated from DR1*, while the minus strand of the type II DL form was elongated from multiple internal acceptor sites (IAS), such as IAS2. These IASs were also found to be used by wild-type HBV but with a very low frequency. Mutation of IAS2 by base substitution abrogated polymerase-linked oligomer transferring to IAS2, demonstrating that base pairing also plays an important role in the function of IAS2 as a polymerase-linked oligomer acceptor site. Data obtained from our insertion mutants also demonstrate that the distance between the polymerase-linked oligomer priming site and the acceptor is important. The polymerase-linked oligomer prefers to translocate to an acceptor, DR1* or IAS2, which are ca. 3.2 kb apart. However, it will translocate to both DR1* and IAS2 if they are not located 3.2 kb apart. These results suggest that the polymerase-linked oligomer may be able to scan bidirectionally for appropriate acceptor sites at a distance of 3.2 kb. A model is proposed to discuss the possible mechanism of polymerase-linked oligomer translocation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982345      PMCID: PMC102097          DOI: 10.1128/jvi.74.19.9010-9018.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.

Authors:  R C Hirsch; D D Loeb; J R Pollack; D Ganem
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.

Authors:  S Staprans; D D Loeb; D Ganem
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  Encapsidation of truncated human hepatitis B virus genomes through trans-complementation of the core protein and polymerase.

Authors:  P W Chiang; C P Hu; T S Su; S C Lo; M H Chu; H Schaller; C M Chang
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

5.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

6.  Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription.

Authors:  M Büscher; W Reiser; H Will; H Schaller
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

7.  Expression and replication of the hepatitis B virus genome under foreign promoter control.

Authors:  M Junker; P Galle; H Schaller
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

8.  Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction.

Authors:  R H Miller; P L Marion; W S Robinson
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

9.  A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

Authors:  M Junker-Niepmann; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription.

Authors:  R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  8 in total

1.  A novel cis-acting element facilitates minus-strand DNA synthesis during reverse transcription of the hepatitis B virus genome.

Authors:  Myeong-Kyun Shin; Jehan Lee; Wang-Shick Ryu
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Base pairing between the 5' half of epsilon and a cis-acting sequence, phi, makes a contribution to the synthesis of minus-strand DNA for human hepatitis B virus.

Authors:  Teresa M Abraham; Daniel D Loeb
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.

Authors:  Ran Hong; Weiya Bai; Jianwei Zhai; Wei Liu; Xinyan Li; Jiming Zhang; Xiaoxian Cui; Xue Zhao; Xiaoli Ye; Qiang Deng; Pierre Tiollais; Yumei Wen; Jing Liu; Youhua Xie
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

4.  Novel reporter system to monitor early stages of the hepatitis B virus life cycle.

Authors:  Hironori Nishitsuji; Saneyuki Ujino; Yuko Shimizu; Keisuke Harada; Jing Zhang; Masaya Sugiyama; Masashi Mizokami; Kunitada Shimotohno
Journal:  Cancer Sci       Date:  2015-10-16       Impact factor: 6.716

Review 5.  Engineering Hepadnaviruses as Reporter-Expressing Vectors: Recent Progress and Future Perspectives.

Authors:  Weiya Bai; Xiaoxian Cui; Youhua Xie; Jing Liu
Journal:  Viruses       Date:  2016-05-10       Impact factor: 5.048

6.  Re-Designed Recombinant Hepatitis B Virus Vectors Enable Efficient Delivery of Versatile Cargo Genes to Hepatocytes with Improved Safety.

Authors:  Weiya Bai; Xiaoxian Cui; Ruidong Chen; Shuai Tao; Ran Hong; Jiming Zhang; Junqi Zhang; Yongxiang Wang; Youhua Xie; Jing Liu
Journal:  Viruses       Date:  2016-05-10       Impact factor: 5.048

Review 7.  Viral strategies of translation initiation: ribosomal shunt and reinitiation.

Authors:  Lyubov A Ryabova; Mikhail M Pooggin; Thomas Hohn
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2002

8.  Isolation and characterization of an exopolymer produced by Bacillus licheniformis: In vitro antiviral activity against enveloped viruses.

Authors:  E Sánchez-León; R Bello-Morales; J A López-Guerrero; A Poveda; J Jiménez-Barbero; N Gironès; C Abrusci
Journal:  Carbohydr Polym       Date:  2020-07-08       Impact factor: 9.381

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.